Crandall Ryan's Form 4 filing
Marimed Inc. (MRMD) · filed Jul 17, 2026
- Accession no.
- 0001522767-26-000157
- Filed
- Jul 17, 2026, 4:12 PM ET
- Trade date
- Jul 15, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Crandall RyanCIK 0002062820 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2026 | Common stock | MOption exerciseAcquired | +32,813 | $0.00F1 | $0 | 1,135,616 | Direct | |
| Jul 15, 2026 | Common stock | FTax withholdingDisposed | −11,370 | $0.0662 | −$752.69 | 1,124,246 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2026 | Common Stock, par value $.001 per share | MOption exerciseDisposed | −32,813 | $0.00 | $0 | 98,437 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
RSUs convert to shares of common stock on a one-for-one basis.
Referenced by the price of 1 transaction in Table I.